1,210
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells

, , , &
Pages 7972-7983 | Received 03 Nov 2021, Accepted 11 Dec 2021, Published online: 31 Mar 2022

References

  • Grasso CS, Wu YM, Robinson DR, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487(7406):239–243.
  • Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med Life. 2017;10(1):5–12.
  • Daniyal M, Siddiqui ZA, Akram M, et al. Epidemiology, etiology, diagnosis and treatment of prostate cancer. Asian Pac J Cancer Prev. 2014;15(22):9575–9578.
  • Bandini M, Fossati N, Gandaglia G, et al. Neoadjuvant and adjuvant treatment in high-risk prostate cancer. Expert Rev Clin Pharmacol. 2018;11(4):425–438.
  • Tilki D, Pompe RS, Bandini M, et al. Local treatment for metastatic prostate cancer: a systematic review. Int J Urol. 2018;25(5):390–403.
  • Adamowicz J, Kluth LA, Pokrywczynska M, et al. Tissue engineering and its potential to reduce prostate cancer treatment sequelae-narrative review. Front Surg. 2021;8:644057.
  • Baden M, Lu L, Drummond FJ, et al. Pain, fatigue and depression symptom cluster in survivors of prostate cancer. Support Care Cancer. 2020;28(10):4813–4824.
  • Moon EH, Kim MJ, Ko KS, et al. Generation of mice with a conditional and reporter allele for Tmem100. Genesis. 2010;48(11):673–678.
  • Moon EH, Kim YH, Vu PN, et al. TMEM100 is a key factor for specification of lymphatic endothelial progenitors. Angiogenesis. 2020;23(3):339–355.
  • Ma J, Yan T, and Bai Y, et al. TMEM100 negatively regulated by microRNA-106b facilitates cellular apoptosis by repressing survivin expression in NSCLC. Oncol Rep. ; 2020; 46 (2): 185 .
  • Han Z, Wang T, Han S, et al. Low-expression of TMEM100 is associated with poor prognosis in non-small-cell lung cancer. Am J Transl Res. 2017;9(5):2567–2578.
  • Zhuang J, Huang Y, Zheng W, et al. TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer. Biol Chem. 2020;401(2):285–296.
  • Chen Y, Bates DL, Dey R, et al. DNA binding by GATA transcription factor suggests mechanisms of DNA looping and long-range gene regulation. Cell Rep. 2012;2(5):1197–1206.
  • Akiyama Y, Watkins N, Suzuki H, et al. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol. 2003;23(23):8429–8439.
  • Enane FO, Shuen WH, Gu X, et al. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition. J Clin Invest. 2017;127(9):3527–3542.
  • Xia L, Gong Y, Zhang A, et al. Loss of GATA5 expression due to gene promoter methylation induces growth and colony formation of hepatocellular carcinoma cells. Oncol Lett. 2016;11(1):861–869.
  • Liu P, Zhou TF, Qiu BA, et al. Methylation-mediated silencing of GATA5 gene suppresses cholangiocarcinoma cell proliferation and metastasis. Transl Oncol. 2018;11(3):585–592.
  • Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.
  • Fornes O, Castro-Mondragon JA, Khan A, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48(D1):D87–d92.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
  • Yang B, Diao H, Wang P, et al. microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1. Bioengineered. 2021;12(1):9094–9102.
  • Fontana F, Moretti RM, Raimondi M, et al. δ-Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells. Cell Prolif. 2019;52(3):e12576.
  • Wu M, Huang Y, Chen T, et al. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis. J Cell Mol Med. 2019;23(1):29–38.
  • Ren D, Yang Q, Dai Y, et al. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. Mol Cancer. 2017;16(1):117.
  • Uygur B, Abramo K, Leikina E, et al. SLUG is a direct transcriptional repressor of PTEN tumor suppressor. Prostate. 2015;75(9):907–916.
  • Ni Z, Lu W, Li Q, et al. Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis. Cancer Biol Med. 2021;18(2):530–546.
  • Guo Y, Balasubramanian B, Zhao ZH, et al. Marine algal polysaccharides alleviate aflatoxin B1-induced bursa of Fabricius injury by regulating redox and apoptotic signaling pathway in broilers. Poult Sci. 2021;100(2):844–857.
  • Barr RD, Ries LA, Lewis DR, et al. Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including ”nonmalignant/noninvasive” tumors. Cancer. 2016;122(7):1000–1008.
  • Litwin MS, Tan HJ. The Diagnosis and Treatment of Prostate Cancer: a Review. Jama. 2017;317(24):2532–2542.
  • Dasgupta P, Davis J, Hughes S. NICE guidelines on prostate cancer 2019. BJU Int. 2019;124(1):1.
  • Gregg JR, Thompson TC. Considering the potential for gene-based therapy in prostate cancer. Nat Rev Urol. 2021;18(3):170–184.
  • Weng HJ, Patel KN, Jeske NA, et al. Tmem100 is a regulator of TRPA1-TRPV1 complex and contributes to persistent pain. Neuron. 2015;85(4):833–846.
  • Somekawa S, Imagawa K, Hayashi H, et al. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis. Proc Natl Acad Sci U S A. 2012;109(30):12064–12069.
  • Carty CL, Johnson NA, Hutter CM, et al. Genome-wide association study of body height in African Americans: the women’s health initiative SNP health association resource (SHARe). Hum Mol Genet. 2012;21(3):711–720.
  • Ou D, Yang H, Hua D, et al. Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma. Oncotarget. 2015;6(19):17379–17390.
  • van der Heul-nieuwenhuijsen L, Hendriksen PJ, van der Kwast Th, et al. Gene expression profiling of the human prostate zones. BJU Int. 2006;98(4):886–897.
  • He Q, Dong Y, Zhu Y, et al. TMEM100 induces cell death in non‑small cell lung cancer via the activation of autophagy and apoptosis. Oncol Rep. 2021;45(5). DOI:10.3892/or.2021.8014
  • Wang J, Zhang C, Wu Y, et al. Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma. Cancer Cell Int. 2019;19:327.
  • Song Z, Chen L, Pang S, et al. Molecular genetic study on GATA5 gene promoter in acute myocardial infarction. PLoS One. 2021;16(3):e0248203.
  • Zhang X, Song YF, Lu HN, et al. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. World J Gastroenterol. 2015;21(9):2629–2637.
  • Zheng R, Blobel GA. GATA Transcription Factors and Cancer. Genes Cancer. 2010;1(12):1178–1188.